Related Experiment Video
Updated: Aug 12, 2026

Selective Harvesting of Marginating-pulmonary Leukocytes
Published on: March 11, 2016
PMA inhibits NK cell generation, cytotoxic activity and NK-1.1 expression
E Ayroldi1, L Cannarile, G Migliorati
1Institute of Pharmacology, University of Perugia, Italy.
Abstract:
We investigated the role of protein kinase C activator phorbol 12-myristate 13-acetate (PMA) on IL-2-driven NK cell differentiation, by using an in vitro model previously set up by our laboratory. Bone marrow precursor cells, from mice treated with 5-fluorouracil (FUBM), when cultured with IL-2, generated mature NK cells. The biochemical system involved in this process has not yet been defined. We investigated the possible mechanism by analyzing the effect of PCK activator PMA on NK cell differentiation and lytic activity of mature NK cells. We now report that: (1) PMA inhibited the IL-2-induced NK cell differentiation and induced development of cells which lyse the NK-resistant target P815. (2) PMA inhibited the lytic ability of mature NK cells against NK-sensitive target YAC-1. We evaluated the effects of PMA using the expression of NK-associated antigen NK-1.1 and the ability to lyse YAC target as parameters of NK cell differentiation. PMA down-regulated both these parameters, reducing their expression during the differentiation process of NK cells and inducing down-modulation of these in mature NK cells. The results suggest that PKC regulatory control could be under the process of differentiation and activation of NK cells.
Insights
Phorbol 12-myristate 13-acetate (PMA) inhibits natural killer (NK) cell differentiation and reduces their lytic activity. Protein kinase C (PKC) activation appears to regulate NK cell differentiation and activation processes.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Interleukin-2 (IL-2) drives natural killer (NK) cell differentiation from bone marrow precursor cells.
- The precise biochemical mechanisms regulating NK cell differentiation and activation remain incompletely understood.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA) in IL-2-driven NK cell differentiation.
- To analyze the effect of PMA on the lytic activity of mature NK cells.
Main Methods:
- Utilized an in vitro model with 5-fluorouracil-treated mouse bone marrow precursor cells (FUBM).
- Cultured FUBM cells with IL-2 to induce NK cell differentiation.
- Assessed NK cell differentiation by measuring NK-1.1 antigen expression and cytotoxic activity against YAC-1 targets.
- Evaluated the impact of PMA on both NK cell differentiation parameters and mature NK cell lytic function.
Main Results:
- PMA inhibited IL-2-induced NK cell differentiation, characterized by down-regulated NK-1.1 expression.
- PMA induced the development of cells with altered lytic activity against NK-resistant P815 targets.
- PMA significantly inhibited the lytic ability of mature NK cells against the NK-sensitive YAC-1 target.
Conclusions:
- Protein kinase C (PKC) activation by PMA exerts inhibitory effects on NK cell differentiation.
- PMA modulates the cytotoxic function of mature NK cells.
- These findings suggest that PKC plays a regulatory role in both the differentiation and activation pathways of NK cells.
Related Concept Videos
Abnormal Proliferation
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

